logo
Select company
Select metric
-60.71%Return on Invested Capital
VS
Market
14
Sector
40
Industry
53
History
7
$ 1.33Close
$ 0.65 - $ 1.97 52-Week Range
Ticker Information

Ticker

BRNS

Company Name

BARINTHUS BIOTHERAPEUTICS PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BARINTHUS BIOTHERAPEUTICS PLC - Return on Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BRNS - ROIC Historical data
DateInvested CapitalNet Income Common StockReturn on Invested Capital
6/30/2025$ 114.36M$ -69.43M-60.71%
3/31/2025$ 127.41M$ -65.23M-51.2%
12/31/2024$ 142.04M$ -61.07M-43%
9/30/2024$ 171.96M$ -57.83M-33.63%
6/30/2024$ 169.19M$ -63.78M-37.7%
3/31/2024$ 184.64M$ -70.66M-38.27%
12/31/2023$ 199.76M$ -73.35M-36.72%
9/30/2023$ 208.1M$ -77.24M-37.12%
6/30/2023$ 229.39M$ -54.93M-23.95%
3/31/2023$ 243.96M$ -15.43M-6.33%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BARINTHUS BIOTHERAPEUTICS PLC's latest trailing twelve months (TTM) ROIC stands at -195.39%.
  • Over the past 5 years, BARINTHUS BIOTHERAPEUTICS PLC's average ROIC has been -36.88%.
  • The median ROIC for BARINTHUS BIOTHERAPEUTICS PLC during this period was -35.17%
  • BARINTHUS BIOTHERAPEUTICS PLC reached its highest ROIC over the past 5 years at 4.53%.
  • The lowest ROIC recorded by BARINTHUS BIOTHERAPEUTICS PLC in the same timeframe -195.39%

BARINTHUS BIOTHERAPEUTICS PLC's ROIC vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROIC Benchmarks
CompanyROIC
VRCA : VERRICA PHARMACEUTICALS INC -227.02%EQ : EQUILLIUM INC -379.94%IRD : OPUS GENETICS INC -315.46%XLO : XILIO THERAPEUTICS INC -384.16%HYFT : MINDWALK HOLDINGS CORP -119.32%CUE : CUE BIOPHARMA INC -150.8%OVID : OVID THERAPEUTICS INC -54.63%SRZN : SURROZEN INC -63.4%PSTV : PLUS THERAPEUTICS INC -620.99%VERU : VERU INC -175.87%

Definition of Return on Invested Capital

[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for BARINTHUS BIOTHERAPEUTICS PLC is calculated as follows: Net Inc. Cmn. [ $ -17.71M ] / Inv. Capital [ $ 9.06M ]
(=) ROIC [ -195.39% ]

BRNS - Return on Invested Capital, Last 5 years

-195.39%

Minimum

Dec 31, 2020

4.53%

Maximum

Sep 30, 2022

-36.88%

Average

-35.17%

Median

ROIC Benchmark Analysis

The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.69% with a standard deviation of 15.18%.
The following table provides additional summary stats:
ROIC in the Market:
filtered constituents3.36K
min-46.36%
max48.66%
average0.69%
median3.38%
std15.18%